Prevention of HIV-1 transmission through breastfeeding: efficacy and safety of maternal antiretroviral therapy versus infant nevirapine prophylaxis for duration of breastfeeding in HIV-1-infected women with high CD4 cell count (IMPAACT PROMISE): a randomized, open label, clinical trial.
Loading...
Date
Authors
Flynn, Patricia M.
Taha, Taha E.
Cababasay, Mae.
Fowler, Mary Glenn.
Mofenson, Lynne Meryl.
Owor, Maxensia.
Fiscus, Susan A.
Stranix-Chibanda, Lynda.
Coutsoudis, Anna.
Gnanashanmugam, Devasena.
Journal Title
Journal ISSN
Volume Title
Publisher
Wolters Kluwer.
Abstract
Abstract available in pdf.
Description
CAPRISA, 2018.
Citation
Flynn, P.M., Taha, T.E., Cababasay, M., Fowler, M.G., Mofenson, L.M., Owor, M., Fiscus, S., Stranix-Chibanda, L., Coutsoudis, A., Gnanashanmugam, D., Chakhtoura, N., McCarthy, K., Mukuzunga, C., Makanani, B., Moodley, D., Nematadzira, T., Kusakara, B., Patil, S., Vhembo, T., Bobat, R., Mmbaga, B.T., Masenya, M., Nyati, M., Theron, G., Mulenga, H., Butler, K. and Shapiro, D.E. 2018. Prevention of HIV-1 transmission through breastfeeding: Efficacy and safety of maternal antiretroviral therapy versus infant nevirapine prophylaxis for duration of breastfeeding in HIV-1-infected women with high CD4 cell count (IMPAACT PROMISE): a randomized, open label, clinical trial. Journal of acquired immune deficiency syndromes 77(4), 383-392.